Channelpedia

Kv7.1 Channel

2168 automatically matched literature references

1

Lang CN et al. Transgenic rabbit models to investigate the cardiac ion channel disease long QT syndrome.
Prog. Biophys. Mol. Biol., 2016 May 19 , ().

3

Ali A et al. Heat shock protein 70 gene polymorphisms' influence on the electrophysiology of long QT syndrome.
J Interv Card Electrophysiol, 2016 Mar , 45 (119-30).

5

Carbonell-Pascual B et al. Comparison between Hodgkin-Huxley and Markov formulations of cardiac ion channels.
J. Theor. Biol., 2016 Jun 21 , 399 (92-102).

6

Yamaguchi Y et al. Latent pathogenicity of the G38S polymorphism of KCNE1 K(+) channel modulator.
Heart Vessels, 2016 Jun 2 , ().

7

Wu W et al. Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology.
Card Electrophysiol Clin, 2016 Jun , 8 (275-84).

13

Al-Hazza A et al. Upregulation of basolateral small conductance potassium channels (KCNQ1/KCNE3) in ulcerative colitis.
Biochem. Biophys. Res. Commun., 2016 Feb 5 , 470 (473-8).

18

Ichikawa M et al. Multigenerational Inheritance of Long QT Syndrome Type 2 in a Japanese Family.
Intern. Med., 2016 , 55 (259-62).

24

Neverisky DL et al. Ion channel-transporter interactions.
Crit. Rev. Biochem. Mol. Biol., 2015 Jul-Aug , 51 (257-67).

25

Neethling A et al. Filamin C: a novel component of the KCNE2 interactome during hypoxia.
Cardiovasc J Afr, 2015 Jan-Feb , 27 (4-11).

29

El-Sherif N et al. Role of pharmacotherapy in cardiac ion channelopathies.
Pharmacol. Ther., 2015 Sep 12 , ().

33

Frea S et al. New echocardiographic insights in short QT syndrome: More than a channelopathy?
Heart Rhythm, 2015 Oct , 12 (2096-105).

34

Andersen MN et al. Protein kinase A stimulates Kv7.1 surface expression by regulating Nedd4-2-dependent endocytic trafficking.
Am. J. Physiol., Cell Physiol., 2015 Nov 15 , 309 (C693-706).

36

Powell KL et al. In response: LQT, HCN, and epilepsy model.
Epilepsia, 2015 Nov , 56 (1855-6).

37

Kodirov SA LQT, HCN, and epilepsy model.
Epilepsia, 2015 Nov , 56 (1855).

38

Vassilakopoulou V et al. Distinctive malfunctions of calmodulin mutations associated with heart RyR2-mediated arrhythmic disease.
Biochim. Biophys. Acta, 2015 Nov , 1850 (2168-76).

39

40

Zoledziewska M et al. Height-reducing variants and selection for short stature in Sardinia.
Nat. Genet., 2015 Nov , 47 (1352-6).

41

Liin SI et al. Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel.
Proc. Natl. Acad. Sci. U.S.A., 2015 May 5 , 112 (5714-9).

43

Leren IS et al. Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.
JACC Cardiovasc Imaging, 2015 May , 8 (501-10).

44

Jahangir A et al. Strain Echocardiography and LQTS Subtypes: Mechanical Alterations in an Electrical Disorder.
JACC Cardiovasc Imaging, 2015 May , 8 (511-3).

46

47

Perry MD et al. Getting to the heart of hERG K(+) channel gating.
J. Physiol. (Lond.), 2015 Mar 27 , ().

48

Goodchild SJ et al. Sequence of gating charge movement and pore gating in HERG activation and deactivation pathways.
Biophys. J., 2015 Mar 24 , 108 (1435-47).

49

Biliczki P et al. The interaction between delayed rectifier channel alpha-subunits does not involve hetero-tetramer formation.
Naunyn Schmiedebergs Arch. Pharmacol., 2015 Mar 20 , ().

50

Steffensen AB et al. IKs Gain- and Loss-of-Function In Early-Onset Lone Atrial Fibrillation.
J. Cardiovasc. Electrophysiol., 2015 Mar 19 , ().

51

52

Gómez-Úriz AM et al. Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells.
Hum. Mol. Genet., 2015 Mar 1 , 24 (1432-40).

53

Laurentino S et al. Epigenetic germline mosaicism in infertile men.
Hum. Mol. Genet., 2015 Mar 1 , 24 (1295-304).

55

Yang L et al. Intravenous anesthetic propofol inhibits multiple human cardiac potassium channels.
Anesthesiology, 2015 Mar , 122 (571-84).

60

61

Liin SI et al. The KCNQ1 channel - remarkable flexibility in gating allows for functional versatility.
J. Physiol. (Lond.), 2015 Jun 15 , 593 (2605-15).

65

Asahara S et al. Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1c.
Proc. Natl. Acad. Sci. U.S.A., 2015 Jul 7 , 112 (8332-7).

66

Stattin EL et al. Genetic screening in sudden cardiac death in the young can save future lives.
Int. J. Legal Med., 2015 Jul 31 , ().

70

Issa NP et al. QT interval prolongation in a patient with LQT2 on levetiracetam.
Seizure, 2015 Jul , 29 (134-6).

79

Nakajo K et al. KCNQ1 channel modulation by KCNE proteins via the voltage-sensing domain.
J. Physiol. (Lond.), 2015 Jan 21 , ().

80

Gayen S et al. Structural analysis of the S4-S5 linker of the human KCNQ1 potassium channel.
Biochem. Biophys. Res. Commun., 2015 Jan 2 , 456 (410-4).

82

Sedivy V et al. Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
Am. J. Physiol. Lung Cell Mol. Physiol., 2015 Jan 1 , 308 (L48-57).

83

Xiong Q et al. Arrhythmogenic cardiomyopathy in a patient with a rare loss-of-function KCNQ1 mutation.
J Am Heart Assoc, 2015 Jan , 4 (e001526).

85

Chen M et al. Pharmacogenomics of glinides.
Pharmacogenomics, 2015 Jan , 16 (45-60).

86

Schultz BM et al. Enhancers compete with a long non-coding RNA for regulation of the Kcnq1 domain.
Nucleic Acids Res., 2015 Jan , 43 (745-59).

88

Riuró H et al. Genetic analysis, in silico prediction, and family segregation in long QT syndrome.
Eur. J. Hum. Genet., 2015 Jan , 23 (79-85).

90

95

Lee S et al. Heterogeneity in Kv7 channel function in the cerebral and coronary circulation.
Microcirculation, 2015 Feb , 22 (109-21).

97

Winbo A et al. Vestibular dysfunction is a clinical feature of the Jervell and Lange-Nielsen Syndrome.
Scand. Cardiovasc. J., 2015 Feb , 49 (7-13).

100

Peters CH et al. Triggers for arrhythmogenesis in the Brugada and long QT 3 syndromes.
Prog. Biophys. Mol. Biol., 2015 Dec 20 , ().

103

Qureshi SF et al. Mutational analysis of SCN5A gene in long QT syndrome.
Meta Gene, 2015 Dec , 6 (26-35).

105

Wasano K et al. A novel frameshift mutation in KCNQ4 in a family with autosomal recessive non-syndromic hearing loss.
Biochem. Biophys. Res. Commun., 2015 Aug 7 , 463 (582-6).

106

107

Yuan J et al. Potassium channel KCNJ15 is required for histamine-stimulated gastric acid secretion.
Am. J. Physiol., Cell Physiol., 2015 Aug 15 , 309 (C264-70).

109

Krönauer T et al. [Perioperative treatment of patients with long QT syndrome].
Anaesthesist, 2015 Aug , 64 (625-39).

110

Krönauer T et al. [Long QT syndrome : History, genetics, clinical symptoms, causes and therapy].
Anaesthesist, 2015 Aug , 64 (586-95).

112

Li G et al. RNA interference-based therapeutics for inherited long QT syndrome.
Exp Ther Med, 2015 Aug , 10 (395-400).

114

Potet F et al. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Circ Arrhythm Electrophysiol, 2015 Aug , 8 (933-41).

115

Winbo A et al. Third trimester fetal heart rate predicts phenotype and mutation burden in the type 1 long QT syndrome.
Circ Arrhythm Electrophysiol, 2015 Aug , 8 (806-14).

117

Lampert R Reassuring News for Genetically Tested, Appropriately Treated, Low-Risk LQTS Patients.
J. Cardiovasc. Electrophysiol., 2015 Aug , 26 (859-61).

119

Osterbur ML et al. An Interdomain KCNH2 Mutation Produces an Intermediate Long QT Syndrome.
Hum. Mutat., 2015 Aug , 36 (764-73).

120

Zhang C et al. Identification of Low-Risk Adult Congenital LQTS Patients.
J. Cardiovasc. Electrophysiol., 2015 Aug , 26 (853-8).

121

Christ T et al. LQT1-phenotypes in hiPSC: Are we measuring the right thing?
Proc. Natl. Acad. Sci. U.S.A., 2015 Apr 21 , 112 (E1968).

122

Greber B et al. Reply to Christ et al.: LQT1 and JLNS phenotypes in hiPSC-derived cardiomyocytes are due to KCNQ1 mutations.
Proc. Natl. Acad. Sci. U.S.A., 2015 Apr 21 , 112 (E1969).

131

Lazzerini PE et al. Long QT Syndrome: An Emerging Role for Inflammation and Immunity.
Front Cardiovasc Med, 2015 , 2 (26).

132

Warsi J et al. Regulation of Voltage Gated K+ Channel KCNE1/KCNQ1 by the Janus Kinase JAK3.
Cell. Physiol. Biochem., 2015 , 37 (2476-85).

134

Bellin M et al. Human iPS cell models of Jervell and Lange-Nielsen syndrome.
Rare Dis, 2015 , 3 (e1012978).

145

146

Itoh H et al. A Common Mutation of Long QT Syndrome Type 1 in Japan.
Circ. J., 2015 , 79 (2026-30).

152

Kılıç E et al. Jervell and Lange-Nielsen syndrome with homozygous missense mutation of the KCNQ1 gene.
Turk. J. Pediatr., 2014 Sep-Oct , 56 (542-5).

153

Mirams GR et al. Prediction of Thorough QT study results using action potential simulations based on ion channel screens.
J Pharmacol Toxicol Methods, 2014 Nov-Dec , 70 (246-54).

155

Hancox JC et al. In silico investigation of a KCNQ1 mutation associated with familial atrial fibrillation.
J Electrocardiol, 2014 Mar-Apr , 47 (158-65).

157

158

van Hoeijen DA et al. Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy.
Expert Opin Pharmacother, 2014 Sep , 15 (1875-87).

163

Imaniastuti R et al. Computational prediction of proarrhythmogenic effect of the V241F KCNQ1 mutation in human atrium.
Prog. Biophys. Mol. Biol., 2014 Sep , 116 (70-5).

165

Singhal R et al. Colchicine suppresses atrial fibrillation in failing heart.
Int. J. Cardiol., 2014 Oct 20 , 176 (651-60).

166

Olde Nordkamp LR et al. Syncope in genotype-negative long QT syndrome family members.
Am. J. Cardiol., 2014 Oct 15 , 114 (1223-8).

168

Sahu ID et al. Structural investigation of the transmembrane domain of KCNE1 in proteoliposomes.
Biochemistry, 2014 Oct 14 , 53 (6392-401).

170

176

Al-Aama JY et al. De novo mutation in the KCNQ1 gene causal to Jervell and Lange-Nielsen syndrome.
Clin. Genet., 2014 Nov , 86 (492-5).

177

Hedley PL et al. MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome.
Scand. J. Clin. Lab. Invest., 2014 May 8 , ().

178

Frolov RV et al. Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol., 2014 May 5 , 730 (61-71).

181

Grunnet M et al. Kv7 channels as targets for anti-epileptic and psychiatric drug-development.
Eur. J. Pharmacol., 2014 Mar 5 , 726 (133-7).

182

Wu J et al. A molecular mechanism for adrenergic-induced long QT syndrome.
J. Am. Coll. Cardiol., 2014 Mar 4 , 63 (819-27).

183

Schwartz PJ et al. Sudden death by stress: how far under the nerves should we dig to find out why LQT1 patients die?
J. Am. Coll. Cardiol., 2014 Mar 4 , 63 (828-30).

186

Brueggemann LI et al. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Am. J. Physiol. Lung Cell Mol. Physiol., 2014 Mar 15 , 306 (L476-86).

188

Shimizu W [Current status and future perspective in inherited cardiac arrhythmias].
Nippon Rinsho, 2014 Mar , 72 (553-63).

192

193

194

Jepps TA et al. Vasorelaxant effects of novel Kv7.4 channel enhancers ML213 and NS15370.
Br. J. Pharmacol., 2014 Jun 9 , ().

197

Currò D K+ channels as potential targets for the treatment of gastrointestinal motor disorders.
Eur. J. Pharmacol., 2014 Jun 15 , 733 (97-101).

198

200

Oliveras A et al. Functional assembly of kv7.1/kv7.5 channels with emerging properties on vascular muscle physiology.
Arterioscler. Thromb. Vasc. Biol., 2014 Jul , 34 (1522-30).

202

Liu W et al. KCNE2 modulates cardiac L-type Ca(2+) channel.
J. Mol. Cell. Cardiol., 2014 Jul , 72 (208-18).

204

Glengarry JM et al. Long QT molecular autopsy in sudden infant death syndrome.
Arch. Dis. Child., 2014 Jul , 99 (635-40).

207

Sakata S et al. Instability of KCNE1-D85N that causes long QT syndrome: stabilization by verapamil.
Pacing Clin Electrophysiol, 2014 Jul , 37 (853-63).

209

Brueggemann LI et al. Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels.
J. Biol. Chem., 2014 Jan 24 , 289 (2099-111).

218

Zhang Y et al. The SCN5A mutation A1180V is associated with electrocardiographic features of LQT3.
Pediatr Cardiol, 2014 Feb , 35 (295-300).

220

Schroder EA et al. Light phase-restricted feeding slows basal heart rate to exaggerate the type-3 long QT syndrome phenotype in mice.
Am. J. Physiol. Heart Circ. Physiol., 2014 Dec 15 , 307 (H1777-85).

222

Aromolaran AS et al. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
Cardiovasc. Res., 2014 Dec 1 , 104 (501-11).

223

Li P et al. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
J. Pharmacol. Exp. Ther., 2014 Dec , 351 (596-604).

224

Salsbury G et al. Disruption of the potassium channel regulatory subunit KCNE2 causes iron-deficient anemia.
Exp. Hematol., 2014 Dec , 42 (1053-8.e1).

226

236

Plant LD et al. Individual IKs channels at the surface of mammalian cells contain two KCNE1 accessory subunits.
Proc. Natl. Acad. Sci. U.S.A., 2014 Apr 8 , 111 (E1438-46).

240

Wang D et al. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths.
Forensic Sci. Int., 2014 Apr , 237 (90-9).

241

Chadha PS et al. Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity.
Arterioscler. Thromb. Vasc. Biol., 2014 Apr , 34 (887-93).

243

Dvir M et al. Recent molecular insights from mutated IKS channels in cardiac arrhythmia.
Curr Opin Pharmacol, 2014 Apr , 15 (74-82).

245

246

Tester DJ et al. GENETICS OF LONG QT SYNDROME.
Methodist Debakey Cardiovasc J, 2014 1 , 10 (29-33).

252

Shimizu W Clinical and genetic diagnosis for inherited cardiac arrhythmias.
J Nippon Med Sch, 2014 , 81 (203-10).

254

Biernacka EK [Genetic arrhythmias and gender].
Prz. Lek., 2014 , 71 (139-41).

256

Miller D et al. Sodium channels, cardiac arrhythmia, and therapeutic strategy.
Adv. Pharmacol., 2014 , 70 (367-92).

258

Villafane J et al. Short QT syndrome manifesting with neonatal atrial fibrillation and bradycardia.
Cardiology, 2014 , 128 (236-40).

262

263

Antzelevitch C et al. The role of late I Na in development of cardiac arrhythmias.
Handb Exp Pharmacol, 2014 , 221 (137-68).

265

269

Zimmer T et al. Voltage-gated sodium channels in the mammalian heart.
Glob Cardiol Sci Pract, 2014 , 2014 (449-63).

270

275

Strutz-Seebohm N et al. Klotho: a new trafficking modifier of Kv7.1/KCNE1 channels.
Channels (Austin), 2014 , 8 (285).

278

Mizusawa Y et al. Genetic and clinical advances in congenital long QT syndrome.
Circ. J., 2014 , 78 (2827-33).

282

Almilaji A et al. Upregulation of KCNQ1/KCNE1 K+ channels by Klotho.
Channels (Austin), 2014 , 8 (222-9).

283

Ertugrul I et al. Follow up of a family with asymptomatic compound long QT syndrome mutations.
Genet. Couns., 2014 , 25 (399-403).

286

Qureshi SF et al. Novel mutations of KCNQ1 in Long QT syndrome.
Indian Heart J, 2013 Sep-Oct , 65 (552-60).

287

Elkins RC et al. Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (112-22).

289

Lang F et al. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth.
Hormones (Athens), 2013 Apr-Jun , 12 (160-71).

290

Svalø J et al. Bladder contractility is modulated by Kv7 channels in pig detrusor.
Eur. J. Pharmacol., 2013 Sep 5 , 715 (312-20).

291

Haugaa KH et al. Abnormal electroencephalograms in patients with long QT syndrome.
Heart Rhythm, 2013 Sep 27 , ().

292

293

294

Haitin Y et al. The structural mechanism of KCNH-channel regulation by the eag domain.
Nature, 2013 Sep 19 , 501 (444-8).

295

Cordeiro JM et al. Developmental changes in expression and biophysics of ion channels in the canine ventricle.
J. Mol. Cell. Cardiol., 2013 Sep 10 , 64C (79-89).

301

Nawathe PA et al. An LQTS6 MiRP1 mutation suppresses pacemaker current and is associated with sinus bradycardia.
J. Cardiovasc. Electrophysiol., 2013 Sep , 24 (1021-7).

305

Kimoto K et al. Characterization of a novel mutant KCNQ1 channel subunit lacking a large part of the C-terminal domain.
Biochem. Biophys. Res. Commun., 2013 Oct 18 , 440 (283-8).

306

Meng J et al. Compound ICA-105574 prevents arrhythmias induced by cardiac delayed repolarization.
Eur. J. Pharmacol., 2013 Oct 15 , 718 (87-97).

309

Giudicessi JR et al. Genotype- and Phenotype-Guided Management of Congenital Long QT Syndrome.
Curr Probl Cardiol, 2013 Oct , 38 (417-455).

310

Andreasen L et al. Genetic Modifier of the QTc Interval Associated With Early-Onset Atrial Fibrillation.
Can J Cardiol, 2013 Oct , 29 (1234-40).

311

Campbell CM et al. Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.
Circ Arrhythm Electrophysiol, 2013 Oct , 6 (960-6).

312

Veerman CC et al. Slow delayed rectifier potassium current blockade contributes importantly to drug-induced long QT syndrome.
Circ Arrhythm Electrophysiol, 2013 Oct , 6 (1002-9).

314

Lee YS et al. Long QT syndrome: a Korean single center study.
J. Korean Med. Sci., 2013 Oct , 28 (1454-60).

316

317

Hummel YM et al. Ventricular dysfunction in a family with long QT syndrome type 3.
Europace, 2013 Oct , 15 (1516-21).

319

321

Li Y et al. Intracellular ATP binding is required to activate the slowly activating K+ channel I(Ks).
Proc. Natl. Acad. Sci. U.S.A., 2013 Nov 19 , 110 (18922-7).

322

Stump MR et al. LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation.
Am. J. Physiol. Heart Circ. Physiol., 2013 Nov 1 , 305 (H1397-404).

324

Di Cori A et al. [Pro-arrhythmic effect of cardiac memory in a patient with long QT syndrome].
G Ital Cardiol (Rome), 2013 Nov , 14 (746-9).

326

329

331

334

Bartos DC et al. A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation.
J. Cardiovasc. Electrophysiol., 2013 May , 24 (562-9).

337

Aziz PF et al. Do LQTS gene single nucleotide polymorphisms alter QTc intervals at rest and during exercise stress testing?
Ann Noninvasive Electrocardiol, 2013 May , 18 (288-93).

339

Werry D et al. Single-channel basis for the slow activation of the repolarizing cardiac potassium current, I(Ks).
Proc. Natl. Acad. Sci. U.S.A., 2013 Mar 12 , 110 (E996-1005).

341

Babcock JJ et al. hERG channel function: beyond long QT.
Acta Pharmacol. Sin., 2013 Mar , 34 (329-35).

346

Steinke K et al. Coxsackievirus B3 modulates cardiac ion channels.
FASEB J., 2013 Jun 27 , ().

350

Heijman J et al. KCNQ1 autoantibodies: another way to regulate IKs.
Cardiovasc. Res., 2013 Jun 1 , 98 (329-31).

351

Rapetti-Mauss R et al. Oestrogen promotes KCNQ1 potassium channel endocytosis and postendocytic trafficking in colonic epithelium.
J. Physiol. (Lond.), 2013 Jun 1 , 591 (2813-31).

352

353

Lang F et al. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.
Expert Opin Investig Drugs, 2013 Jun , 22 (701-14).

359

Brelidze TI et al. Structure of the C-terminal region of an ERG channel and functional implications.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jul 9 , 110 (11648-53).

360

361

Amin AS et al. Long QT syndrome: beyond the causal mutation.
J. Physiol. (Lond.), 2013 Jul 22 , ().

362

Zaydman MA et al. Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jul 16 , ().

364

Takanari H et al. Efficient and specific cardiac IK1 inhibition by a new pentamidine analogue.
Cardiovasc. Res., 2013 Jul 1 , 99 (203-14).

371

Nguyen N et al. Independent trafficking of the KCNQ1 K+ channel and H+-K+-ATPase in gastric parietal cells from mice.
Am. J. Physiol. Gastrointest. Liver Physiol., 2013 Jan 15 , 304 (G157-66).

374

Abbott GW KCNE genetics and pharmacogenomics in cardiac arrhythmias: much ado about nothing?
Expert Rev Clin Pharmacol, 2013 Jan , 6 (49-60).

382

Feng MJ et al. [KCNQ1 mutation in patients with lone atrial fibrillation].
Zhonghua Xin Xue Guan Bing Za Zhi, 2013 Jan , 41 (8-12).

385

Yang T et al. An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1.
Mol. Pharmacol., 2013 Feb , 83 (481-9).

386

Melnick M et al. An in vitro mouse model of congenital cytomegalovirus-induced pathogenesis of the inner ear cochlea.
Birth Defects Res. Part A Clin. Mol. Teratol., 2013 Feb , 97 (69-78).

388

Ware JS et al. Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches.
J Cardiovasc Transl Res, 2013 Feb , 6 (94-103).

391

Nguyen HL et al. Andersen-Tawil syndrome: clinical and molecular aspects.
Int. J. Cardiol., 2013 Dec 5 , 170 (1-16).

393

Seebohm G A complex partnership: KCNQ1 and KCNE1.
Biophys. J., 2013 Dec 3 , 105 (2437-8).

397

Khanamiri S et al. Contribution of Kv7 channels to basal coronary flow and active response to ischemia.
Hypertension, 2013 Dec , 62 (1090-7).

401

Than BL et al. The role of KCNQ1 in mouse and human gastrointestinal cancers.
Oncogene, 2013 Aug 26 , ().

402

Hayashi M et al. Molecular basis of potassium channels in pancreatic duct epithelial cells.
Channels (Austin), 2013 Aug 20 , 7 ().

411

Cheng J et al. Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.
J. Mol. Cell. Cardiol., 2013 Aug , 61 (102-10).

414

Crotti L et al. Long QT syndrome-associated mutations in intrauterine fetal death.
JAMA, 2013 Apr 10 , 309 (1473-82).

415

Hu RM et al. Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
Am. J. Physiol. Heart Circ. Physiol., 2013 Apr 1 , 304 (H994-H1001).

419

424

Moric-Janiszewska E et al. Quantitative PCR as an Alternative in the Diagnosis of Long-QT Syndrome.
Biomed Res Int, 2013 , 2013 (418604).

427

428

Netchine I et al. Epigenetic anomalies in childhood growth disorders.
Nestle Nutr Inst Workshop Ser, 2013 , 71 (65-73).

435

Ferrer T et al. Tamoxifen inhibition of kv7.2/kv7.3 channels.
PLoS ONE, 2013 , 8 (e76085).

442

Hekkala AM et al. T-wave morphology after epinephrine bolus may reveal silent long QT syndrome mutation carriers.
J Electrocardiol, 2012 Jul-Aug , 45 (368-72).

447

Zumhagen S et al. Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.
Herzschrittmacherther Elektrophysiol, 2012 Sep , 23 (211-9).

453

Haugaa KH et al. Subclinical Cardiomyopathy and Long QT Syndrome: An Echocardiographic Observation.
Congenit Heart Dis, 2012 Oct 24 , ().

454

Abderemane-Ali F et al. Dual effect of phosphatidyl (4,5)-bisphosphate PIP2 on Shaker K+ channels.
J. Biol. Chem., 2012 Oct 19 , 287 (36158-67).

459

Mannino GC et al. Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
Mol Diagn Ther, 2012 Oct , 16 (285-302).

462

467

Edelmann J et al. Long QT syndrome mutation detection by SNaPshot technique.
Int. J. Legal Med., 2012 Nov , 126 (969-73).

471

Wilmes J et al. Regulation of KCNQ1/KCNE1 by β-catenin.
, 2012 May 14 , ().

472

Osteen JD et al. Allosteric gating mechanism underlies the flexible gating of KCNQ1 potassium channels.
Proc. Natl. Acad. Sci. U.S.A., 2012 May 1 , 109 (7103-8).

476

Birner C et al. Differential expression of potassium channels and abnormal conduction in experimental tachycardia-induced heart failure.
Naunyn Schmiedebergs Arch. Pharmacol., 2012 May , 385 (473-80).

483

Pattnaik BR et al. Effects of KCNQ channel modulators on the M-type potassium current in primate retinal pigment epithelium.
Am. J. Physiol., Cell Physiol., 2012 Mar , 302 (C821-33).

485

Moreno JD et al. Pathophysiology of the cardiac late Na current and its potential as a drug target.
J. Mol. Cell. Cardiol., 2012 Mar , 52 (608-19).

486

Besana A et al. Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome.
J. Cardiovasc. Pharmacol., 2012 Mar , 59 (249-53).

487

489

Kaddar N et al. Tizanidine (Zanaflex): a muscle relaxant that may prolong the QT interval by blocking IKr.
J. Cardiovasc. Pharmacol. Ther., 2012 Mar , 17 (102-9).

490

Gönczi M et al. Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys., 2012 Jun , 31 (153-62).

496

Kulzer M et al. Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230A.
Biochem. Biophys. Res. Commun., 2012 Jul 27 , 424 (315-20).

499

Hayashi M et al. An intermediate-conductance Ca2+-activated K+ channel is important for secretion in pancreatic duct cells.
Am. J. Physiol., Cell Physiol., 2012 Jul 15 , 303 (C151-9).

502

Vandenberg JI et al. hERG K(+) channels: structure, function, and clinical significance.
Physiol. Rev., 2012 Jul , 92 (1393-478).

512

Krishnan Y et al. Partially dominant mutant channel defect corresponding with intermediate LQT2 phenotype.
Pacing Clin Electrophysiol, 2012 Jan , 35 (3-16).

513

Andersen MN et al. AMP-activated protein kinase downregulates Kv7.1 cell surface expression.
Traffic, 2012 Jan , 13 (143-56).

518

Dennis AT et al. Molecular determinants of pentamidine-induced hERG trafficking inhibition.
Mol. Pharmacol., 2012 Feb , 81 (198-209).

519

524

Abriel H et al. Cardiac channelopathies: Genetic and molecular mechanisms.
Gene, 2012 Dec 22 , ().

526

Ishii K et al. Endocytic regulation of voltage-dependent potassium channels in the heart.
J. Pharmacol. Sci., 2012 Dec 18 , 120 (264-9).

527

Organ-Darling LE et al. Interactions between hERG and KCNQ1 α-subunits are mediated by their C-termini and modulated by cAMP.
Am. J. Physiol. Heart Circ. Physiol., 2012 Dec 15 , ().

529

530

532

Fedoriw AM et al. Differentiation-driven nucleolar association of the mouse imprinted Kcnq1 locus.
G3 (Bethesda), 2012 Dec , 2 (1521-8).

533

535

Wang Y et al. Probing the structural basis for differential KCNQ1 modulation by KCNE1 and KCNE2.
J. Gen. Physiol., 2012 Dec , 140 (653-69).

537

539

Ware JS et al. Paralogous annotation of disease-causing variants in long QT syndrome genes.
Hum. Mutat., 2012 Aug , 33 (1188-91).

540

Purtell K et al. The KCNQ1-KCNE2 K⁺ channel is required for adequate thyroid I⁻ uptake.
FASEB J., 2012 Aug , 26 (3252-9).

542

Song W et al. Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia.
Pediatr Cardiol, 2012 Aug , 33 (943-9).

544

Jiménez-Vargas JM et al. Toxin modulators and blockers of hERG K(+) channels.
, 2012 Apr 5 , ().

552

Komarlu R et al. Fetal and neonatal presentation of long QT syndrome.
Pacing Clin Electrophysiol, 2012 Apr , 35 (e87-90).

553

Couderc JP et al. Genotype- and Sex-Specific QT-RR Relationship in the Type-1 Long-QT Syndrome.
J Am Heart Assoc, 2012 Apr , 1 (e000570).

557

Morris LM et al. Mouse middle ear ion homeostasis channels and intercellular junctions.
PLoS ONE, 2012 , 7 (e39004).

563

Knoche JW et al. Atrial Fibrillation and Long QT Syndrome Presenting in a 12-Year-Old Girl.
Case Rep Pediatr, 2012 , 2012 (124838).

573

Lazarczyk MJ et al. Selective acquired long QT syndrome (saLQTS) upon risperidone treatment.
BMC Psychiatry, 2012 , 12 (220).

577

Ferro F et al. Long-chain acylcarnitines regulate the hERG channel.
PLoS ONE, 2012 , 7 (e41686).

578

Moric-Janiszewska E et al. Molecular diagnostics of families with long-QT syndrome.
Cardiol J, 2012 , 19 (159-67).

584

Dennis AT et al. Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERG.
J. Biol. Chem., 2011 Sep 30 , 286 (34413-25).

587

589

Digby GC et al. Acquired long QT interval: a case series of multifactorial QT prolongation.
Clin Cardiol, 2011 Sep , 34 (577-82).

598

599

Calloe K et al. Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A.
Can. J. Physiol. Pharmacol., 2011 Oct , 89 (723-36).

600

Tester DJ et al. Unexplained drownings and the cardiac channelopathies: a molecular autopsy series.
Mayo Clin. Proc., 2011 Oct , 86 (941-7).

602

Bonaldi A et al. Microduplication of the ICR2 domain at chromosome 11p15 and familial Silver-Russell syndrome.
Am. J. Med. Genet. A, 2011 Oct , 155A (2479-83).

613

Nakajo K et al. KCNQ1 subdomains involved in KCNE modulation revealed by an invertebrate KCNQ1 orthologue.
J. Gen. Physiol., 2011 Nov , 138 (521-35).

614

Parvez B et al. The "missing" link in atrial fibrillation heritability.
J Electrocardiol, 2011 Nov , 44 (641-4).

615

Kaufman ES Arrhythmic risk in congenital long QT syndrome.
J Electrocardiol, 2011 Nov , 44 (645-9).

618

Bai YL et al. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
J. Mol. Cell. Cardiol., 2011 Nov , 51 (876-80).

619

Saif-Ali R et al. KCNQ1 variants associate with type 2 diabetes in Malaysian Malay subjects.
Ann. Acad. Med. Singap., 2011 Nov , 40 (488-92).

625

626

Jespersen T Regulation and physiological function of Na(v) 1.5 and KCNQ1 channels.
Acta Physiol (Oxf), 2011 May , 202 Suppl 683 (1-26).

627

629

Ando F et al. Synergic effects of β-estradiol and erythromycin on hERG currents.
J. Membr. Biol., 2011 May , 241 (31-8).

632

Soma K et al. Abundant expression of KCNE1 in the left ventricle of the miniature pig.
Heart Vessels, 2011 May , 26 (353-6).

643

Papatheodoropoulos C et al. α5GABAA receptors regulate hippocampal sharp wave-ripple activity in vitro.
Neuropharmacology, 2011 Mar , 60 (662-73).

645

647

655

Zhou PZ et al. Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules.
Acta Pharmacol. Sin., 2011 Jun , 32 (781-8).

656

Vigneault P et al. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
J. Cardiovasc. Pharmacol., 2011 Jun , 57 (690-5).

658

Kanduri C Kcnq1ot1: a chromatin regulatory RNA.
Semin. Cell Dev. Biol., 2011 Jun , 22 (343-50).

659

Obata Y et al. Epigenetically immature oocytes lead to loss of imprinting during embryogenesis.
J. Reprod. Dev., 2011 Jun , 57 (327-34).

662

Schroner Z et al. Variation in KCNQ1 is associated with therapeutic response to sulphonylureas.
Med. Sci. Monit., 2011 Jul , 17 (CR392-6).

663

Jones MJ et al. An extended domain of Kcnq1ot1 silencing revealed by an imprinted fluorescent reporter.
Mol. Cell. Biol., 2011 Jul , 31 (2827-37).

666

Couderc JP et al. T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition.
Heart Rhythm, 2011 Jul , 8 (1036-43).

667

Allegue C et al. Prevalence of HCM and long QT syndrome mutations in young sudden cardiac death-related cases.
Int. J. Legal Med., 2011 Jul , 125 (565-72).

668

Tveito A et al. Defining candidate drug characteristics for Long-QT (LQT3) syndrome.
Math Biosci Eng, 2011 Jul , 8 (861-73).

672

675

Thomas AM et al. Characterization of a binding site for anionic phospholipids on KCNQ1.
J. Biol. Chem., 2011 Jan 21 , 286 (2088-100).

676

Kauferstein S et al. A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS.
Int. J. Cardiol., 2011 Jan 21 , 146 (249-50).

681

Han S et al. Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.
Eur. J. Pharmacol., 2011 Jan 10 , 650 (138-44).

682

684

Stump MR et al. Multiple splicing defects caused by hERG splice site mutation 2592+1G>A associated with long QT syndrome.
Am. J. Physiol. Heart Circ. Physiol., 2011 Jan , 300 (H312-8).

687

Fröhlich H et al. Hypothyroidism of gene-targeted mice lacking Kcnq1.
Pflugers Arch., 2011 Jan , 461 (45-52).

688

691

693

Ma LJ et al. Allosteric Features of KCNQ1 Gating Revealed by Alanine Scanning Mutagenesis.
Biophys. J., 2011 Feb 16 , 100 (885-94).

697

699

Li JL et al. [Association of age-related hearing loss with ion transporter KCNQ1 and NKCC1 in cochlea of C57BL/6J mice].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2011 Feb , 46 (139-43).

700

Bentzen BH et al. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.
J. Cardiovasc. Pharmacol., 2011 Feb , 57 (223-30).

706

Maillé E et al. Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-α after injury.
Am. J. Physiol. Lung Cell Mol. Physiol., 2011 Dec , 301 (L945-55).

707

Mikuni I et al. Partial restoration of the long QT syndrome associated KCNQ1 A341V mutant by the KCNE1 β-subunit.
Biochim. Biophys. Acta, 2011 Dec , 1810 (1285-93).

709

710

Krause U et al. A rare association of long QT syndrome and syndactyly: Timothy syndrome (LQT 8).
Clin Res Cardiol, 2011 Dec , 100 (1123-7).

711

Chen J et al. A dual mechanism for I(Ks) current reduction by the pathogenic mutation KCNQ1-S277L.
Pacing Clin Electrophysiol, 2011 Dec , 34 (1652-64).

712

Sung RK et al. QTc prolongation and family history of sudden death in a patient with desmin cardiomyopathy.
Pacing Clin Electrophysiol, 2011 Dec , 34 (e105-8).

714

Shao C et al. Electrophysiological study of V535M hERG mutation of LQT2.
J. Huazhong Univ. Sci. Technol. Med. Sci., 2011 Dec , 31 (741-8).

716

717

Lin S et al. Nonallelic transcriptional roles of CTCF and cohesins at imprinted loci.
Mol. Cell. Biol., 2011 Aug , 31 (3094-104).

723

Yamagata K et al. Voltage-gated K+ channel KCNQ1 regulates insulin secretion in MIN6 β-cell line.
Biochem. Biophys. Res. Commun., 2011 Apr 15 , 407 (620-5).

726

El Gebeily G et al. Upregulation of ventricular potassium channels by chronic tamoxifen treatment.
Cardiovasc. Res., 2011 Apr 1 , 90 (68-76).

727

Andersen MN et al. Kv7.1 surface expression is regulated by epithelial cell polarization.
Am. J. Physiol., Cell Physiol., 2011 Apr , 300 (C814-24).

728

Van Horn WD et al. Working model for the structural basis for KCNE1 modulation of the KCNQ1 potassium channel.
Curr. Opin. Struct. Biol., 2011 Apr , 21 (283-91).

730

Winbo A et al. Origin of the Swedish long QT syndrome Y111C/KCNQ1 founder mutation.
Heart Rhythm, 2011 Apr , 8 (541-7).

732

Grilo LS et al. Patient with syncope and LQTS carrying a mutation in the PAS domain of the hERG1 channel.
Ann Noninvasive Electrocardiol, 2011 Apr , 16 (213-8).

734

Lahtinen AM et al. KCNE1 D85N polymorphism - a sex-specific modifier in type 1 long QT syndrome?
BMC Med. Genet., 2011 , 12 (11).

736

Namekata I et al. Blocking effect of NIP-142 on the KCNQ1/KCNE1 channel current expressed in HEK293 cells.
Biol. Pharm. Bull., 2011 , 34 (153-5).

741

Frolov RV et al. Inhibition of HERG potassium channels by celecoxib and its mechanism.
PLoS ONE, 2011 , 6 (e26344).

742

Rotte A et al. Ca2+ activated K+ channel Kca3.1 as a determinant of gastric acid secretion.
Cell. Physiol. Biochem., 2011 , 27 (597-604).

743

Strutz-Seebohm N et al. Structural basis of slow activation gating in the cardiac I Ks channel complex.
Cell. Physiol. Biochem., 2011 , 27 (443-52).

744

Zareba W Counting mRNA in blood of LQTS - new direction?
Kardiol Pol, 2011 , 69 (430).

748

Yun J et al. Hirsutenone directly blocks human ether-a-go-go related gene K+ channels.
Biol. Pharm. Bull., 2011 , 34 (1815-22).

751

Saif-Ali R et al. KCNQ1 haplotypes associate with type 2 diabetes in Malaysian Chinese Subjects.
Int J Mol Sci, 2011 , 12 (5705-18).

752

Couderc JP et al. Short and long QT syndromes: does QT length really matter?
J Electrocardiol, 2010 Sep-Oct , 43 (396-9).

753

Lang F et al. SGK, renal function and hypertension.
J. Nephrol., 2010 Nov-Dec , 23 Suppl 16 (S124-9).

754

Cirović S et al. Differential expression of KCNQ1 K+ channel in tubular cells of frog kidney.
Eur J Histochem, 2010 Jan-Mar , 54 (e7).

761

Zhong XZ et al. Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.
J. Physiol. (Lond.), 2010 Sep 1 , 588 (3277-93).

762

Nanda Kumar NS et al. Mucosal potassium efflux mediated via Kcnn4 channels provides the driving force for electrogenic anion secretion in colon.
Am. J. Physiol. Gastrointest. Liver Physiol., 2010 Sep , 299 (G707-14).

763

Bokil NJ et al. Molecular genetics of long QT syndrome.
Mol. Genet. Metab., 2010 Sep , 101 (1-8).

764

Moretti A et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
N. Engl. J. Med., 2010 Oct 7 , 363 (1397-409).

765

Nakajo K et al. Stoichiometry of the KCNQ1 - KCNE1 ion channel complex.
, 2010 Oct 20 , ().

769

770

Dautova Y et al. Atrial arrhythmogenic properties in wild-type and Scn5a+/- murine hearts.
Exp. Physiol., 2010 Oct , 95 (994-1007).

775

Roura-Ferrer M et al. Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface targeting.
J. Cell. Physiol., 2010 Nov , 225 (692-700).

776

Garweg C et al. [The long QT syndrome].
Rev Med Liege, 2010 Nov , 65 (628-33).

777

Schubert ML Gastric secretion.
Curr. Opin. Gastroenterol., 2010 Nov , 26 (598-603).

778

Purtell K et al. Cardiac arrhythmia and thyroid dysfunction: a novel genetic link.
Int. J. Biochem. Cell Biol., 2010 Nov , 42 (1767-70).

779

Sy RW et al. Repolarization dynamics during exercise discriminate between LQT1 and LQT2 genotypes.
J. Cardiovasc. Electrophysiol., 2010 Nov , 21 (1242-6).

784

Dong MQ et al. Regulation of human cardiac KCNQ1/KCNE1 channel by epidermal growth factor receptor kinase.
Biochim. Biophys. Acta, 2010 May , 1798 (995-1001).

785

Eldstrom J et al. Mechanistic basis for LQT1 caused by S3 mutations in the KCNQ1 subunit of IKs.
J. Gen. Physiol., 2010 May , 135 (433-48).

786

Allegue C et al. A new approach to long QT syndrome mutation detection by Sequenom MassARRAY system.
Electrophoresis, 2010 May , 31 (1648-55).

787

791

Lu JT et al. Recent progress in congenital long QT syndrome.
, 2010 Mar 10 , ().

794

Fink M et al. Pharmacodynamic effects in the cardiovascular system: the modeller's view.
Basic Clin. Pharmacol. Toxicol., 2010 Mar , 106 (243-9).

795

Pan Q et al. KCNQ1 loss-of-function mutation impairs gastric acid secretion in mice.
Mol. Biol. Rep., 2010 Mar , 37 (1329-33).

797

Vanoye CG et al. KCNQ1/KCNE1 assembly, co-translation not required.
Channels (Austin), 2010 Mar , 4 (108-14).

800

Yang Y et al. Identification of a Kir3.4 mutation in congenital long QT syndrome.
Am. J. Hum. Genet., 2010 Jun 11 , 86 (872-80).

802

Lin EC et al. Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes.
Am. J. Physiol. Heart Circ. Physiol., 2010 Jun , 298 (H1842-9).

811

Fabritz L et al. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
Cardiovasc. Res., 2010 Jul 1 , 87 (60-72).

813

Sanguinetti MC HERG1 channelopathies.
Pflugers Arch., 2010 Jul , 460 (265-76).

815

817

Ponte ML et al. Mechanisms of Drug Induced QT Interval Prolongation.
Curr Drug Saf, 2010 Jan 1 , 5 (44-53).

819

Shin HD et al. Association of KCNQ1 polymorphisms with the gestational diabetes mellitus in Korean women.
J. Clin. Endocrinol. Metab., 2010 Jan , 95 (445-9).

820

Lang F et al. Heterocyclic indazole derivatives as SGK1 inhibitors, WO2008138448.
Expert Opin Ther Pat, 2010 Jan , 20 (129-35).

824

Charpentier F et al. Delayed rectifier K(+) currents and cardiac repolarization.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (37-44).

826

Thomas D et al. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (230-7).

827

Alvarez PA et al. QT alterations in psychopharmacology: proven candidates and suspects.
Curr Drug Saf, 2010 Jan , 5 (97-104).

828

Banderali U et al. Impaired stretch modulation in potentially lethal cardiac sodium channel mutants.
Channels (Austin), 2010 Jan , 4 (12-21).

829

830

832

Kang C et al. Functional delivery of a membrane protein into oocyte membranes using bicelles.
Biochemistry, 2010 Feb 2 , 49 (653-5).

833

Bal M et al. Ca2+/calmodulin disrupts AKAP79/150 interactions with KCNQ (M-Type) K+ channels.
J. Neurosci., 2010 Feb 10 , 30 (2311-23).

834

Saba S et al. Effect of right ventricular versus biventricular pacing on electrical remodeling in the normal heart.
Circ Arrhythm Electrophysiol, 2010 Feb 1 , 3 (79-87).

836

Harmer SC et al. Mechanisms of disease pathogenesis in long QT syndrome type 5.
Am. J. Physiol., Cell Physiol., 2010 Feb , 298 (C263-73).

839

Grallert H et al. Association of genetic variation in KCNQ1 with type 2 diabetes in the KORA surveys.
Horm. Metab. Res., 2010 Feb , 42 (149-51).

840

Lian J et al. [A novel mutation of the KCNH2 gene in a family with congenital long QT syndrome]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2010 Feb , 27 (77-80).

841

Jing H et al. Ephedrine controls heart rhythms by activating cardiac I(ks) currents.
J. Cardiovasc. Pharmacol., 2010 Feb , 55 (145-52).

842

Serratrice G et al. [Potassium channelopathies and Morvan's syndromes].
Bull. Acad. Natl. Med., 2010 Feb , 194 (391-406; discussion 406-7).

843

Osteen JD et al. KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 channel gate.
Proc. Natl. Acad. Sci. U.S.A., 2010 Dec 28 , 107 (22710-5).

844

Wu D et al. KCNE1 remodels the voltage sensor of Kv7.1 to modulate channel function.
Biophys. J., 2010 Dec 1 , 99 (3599-608).

845

846

Cao X et al. Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system.
Assay Drug Dev Technol, 2010 Dec , 8 (766-80).

848

Kim HT et al. Long QT syndrome provoked by induction of general anesthesia -A case report-.
Korean J Anesthesiol, 2010 Dec , 59 Suppl (S114-8).

849

853

Kim JA et al. Trigger-specific risk factors and response to therapy in long QT syndrome type 2.
Heart Rhythm, 2010 Dec , 7 (1797-805).

857

Zhang T et al. LQTS gene LOVD database.
, 2010 Aug 31 , ().

860

Choufani S et al. Beckwith-Wiedemann syndrome.
Am J Med Genet C Semin Med Genet, 2010 Aug 15 , 154C (343-54).

861

Weaver JR et al. Domain-specific response of imprinted genes to reduced DNMT1.
Mol. Cell. Biol., 2010 Aug , 30 (3916-28).

862

Stead LF et al. KvDB; mining and mapping sequence variants in voltage-gated potassium channels.
Hum. Mutat., 2010 Aug , 31 (908-17).